Last reviewed · How we verify
Sialic Acid-Extended Release — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Sialic Acid-Extended Release (Sialic Acid-Extended Release) — Hadassah Medical Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sialic Acid-Extended Release TARGET | Sialic Acid-Extended Release | Hadassah Medical Organization | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sialic Acid-Extended Release CI watch — RSS
- Sialic Acid-Extended Release CI watch — Atom
- Sialic Acid-Extended Release CI watch — JSON
- Sialic Acid-Extended Release alone — RSS
Cite this brief
Drug Landscape (2026). Sialic Acid-Extended Release — Competitive Intelligence Brief. https://druglandscape.com/ci/sialic-acid-extended-release. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing